Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (unaudited)

v3.6.0.2
Condensed Consolidated Statements of Operations (unaudited) - USD ($)
3 Months Ended 6 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2016
Dec. 31, 2015
Income Statement [Abstract]        
Contract research and government grants $ 159,068 $ 159,068
Operating expenses        
Research and development 775,984 351,892 1,428,560 673,612
General and administrative expenses 2,066,768 724,481 3,330,011 1,485,804
Total operating expenses 2,842,752 1,076,373 4,758,571 2,159,416
Loss from operations (2,683,684) (1,076,373) (4,599,503) (2,159,416)
Other income (expense)        
Interest income 209 352 299 848
Change in fair value of derivative liabilities (712,246) 5,414 (869,462) 19,429
Total other income (expense) (712,037) 5,766 (869,163) 20,277
Net loss $ (3,395,721) $ (1,070,607) $ (5,468,666) $ (2,139,139)
Net loss per common share - basic and diluted (in dollars per share) $ (0.21) $ (0.08) $ (0.35) $ (0.18)
Weighted average common shares outstanding - basic and diluted (in shares) 15,892,503 12,768,358 15,797,106 12,036,767